R

Ryder System, Inc.
$244.00
+5.55 (+2.33%)
Mkt Cap 9.44B
Volume 441,902
52W Range 143.34-259
Sector Industrials
Beta 1.03
EPS (TTM) 12.13
P/E Ratio 20.12
Revenue (TTM) 12.69B
Rev Growth (5Y) +8.5%
EPS Growth (5Y) +10.5%
AlphaVal · Fair Value
$717.74
Undervalued · Strong
66.0% below fair value
AlphaQuality · Grade
C-
Platform & Compounding FCF
49.3 / 100 composite

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 12.69B 12.71B 11.98B 12.46B 9.92B 8.42B 8.87B 8.39B 7.26B 6.76B 6.57B 6.64B
Net Income 499.00M 489.00M 406.00M 867.00M 519.00M (122.00M) (24.41M) 284.61M 719.64M 263.07M 304.80M 218.60M
EPS 12.20 11.29 9.20 17.40 9.94 -2.34 -0.45 5.22 13.63 4.95 5.75 4.14
Free Cash Flow 459.00M (418.00M) (881.00M) (321.00M) 234.00M 1.03B (1.59B) (1.42B) (312.45M) (304.13M) N/A N/A
FCF / Share 10.98 -9.70 -20.07 -6.48 4.47 19.77 -30.46 -27.01 -5.94 -5.74 N/A N/A
Operating CF 2.59B 2.27B 2.35B 2.31B 2.17B 2.18B 2.14B 1.64B 1.55B 1.60B N/A N/A
Total Assets 16.39B 16.67B 15.78B 14.39B 13.84B 12.93B 14.48B 13.35B 11.46B 10.90B N/A N/A
Total Debt 8.68B 8.88B 8.15B 7.08B 6.94B 6.88B 8.15B 6.86B 5.41B 5.39B N/A N/A
Cash & Equiv 198.00M 154.00M 204.00M 267.00M 234.00M 151.29M 73.58M 68.11M 78.35M 58.80M N/A N/A
Book Value 3.05B 3.12B 3.07B 2.94B 2.80B 2.26B 2.48B 2.54B 2.84B 2.05B N/A N/A
Return on Equity 0.16 0.16 0.13 0.30 0.19 -0.05 -0.01 0.11 0.25 0.13 N/A N/A
R News
BioInvent Reveals Solid Data with its TNFR2 Antibody BI-1808 and KEYTRUDA(R) (pembrolizumab) in Advanced Ovarian Cancer at ASCO
May 21, 2026 01:30 PM · accessnewswire.com
Theralase(R) Closes C$4.8 Million Offering
May 20, 2026 07:06 AM · newsfilecorp.com
Vera Quinn of Cydcor Named Entrepreneur Of the Year(R) 2026 Greater Los Angeles Finalist by EY US
May 19, 2026 09:00 AM · newsfilecorp.com
GMG's THERMAL-XR(R) to be Applied Exclusively & Distributed to Global Oil and Gas/LNG Industry with Curran International
May 19, 2026 04:05 AM · newsfilecorp.com
Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM 2026 Conference
May 17, 2026 10:40 PM · accessnewswire.com
Are Investors Undervaluing Ryder System (R) Right Now?
May 14, 2026 06:41 AM · zacks.com
Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program
May 13, 2026 05:00 AM · accessnewswire.com
Tenon(R) Medical Reports First Quarter 2026 Financial Results
May 12, 2026 12:05 PM · accessnewswire.com
Ryder System, Inc. (R) Presents at Bank of America 33rd Annual Industrials, Transportation and Airlines Key Leaders Conference Transcript
May 12, 2026 09:40 AM · seekingalpha.com
BioInvent's TNFR2 Antibody BI-1808 Shows Strong Activity and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026)
May 12, 2026 06:00 AM · accessnewswire.com